Courneya KS et al., 2025-07-03: CHALLENGE, a randomised trial in 889 patients after adjuvant chemotherapy for colon cancer: a three-year structured exercise programme lengthened disease-free survival (HR 0.72) and showed overall survival consistent with benefit (HR 0.63), with more musculoskeletal adverse events.
disease-free survival was significantly longer in the exercise group than in the health-education group (hazard ratio for disease recurrence, new primary cancer, or death, 0.72; 95% confidence interval [CI], 0.55 to 0.94; P = 0.02).
Abstract, Results
Courneya KS et al., 2025-07-03: CHALLENGE, a randomised trial in 889 patients after adjuvant chemotherapy for colon cancer: a three-year structured exercise programme lengthened disease-free survival (HR 0.72) and showed overall survival consistent with benefit (HR 0.63), with more musculoskeletal adverse events. Median follow-up 7.9 years; comparator was a health-education programme, not usual care, which controls for attention. 'Funded by the Canadian Cancer Society and others' (abstract); individual author disclosures not captured. Trial NCT00819208. Study type: randomized trial.
